Anti HIV-1 agents 5: Synthesis and anti-HIV-1 activity of some N-arylsulfonyl-3-acetylindoles in vitro

被引：35
|
作者：
Ran, Jun-Qiang [1 ]
Huang, Ning [2 ]
Xu, Hui [1 ]
Yang, Liu-Meng [2 ]
Lv, Min [1 ]
Zheng, Yong-Tang [2 ]
机构：
[1] NW A&F Univ, Coll Sci, Lab Pharmaceut Design & Synth, Yangling 712100, Peoples R China
[2] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech Chinese Acad, Kunming 650223, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 12期
关键词：
N-Arylsulfonyl-3-acetylindole; Acquired immune-deficiency syndrome; Human immunodeficiency virus-1; Inhibitor;
D O I：
10.1016/j.bmcl.2010.04.132
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
In continuation of our program aimed at the discovery and development of compounds with superior anti-human immunodeficiency virus type 1 (HIV-1) activity, 21N-arylsulfonyl-3-acetylindole analogs (2a-u) were synthesized and preliminarily evaluated as HIV-1 inhibitors in vitro. Among of all the analogs, several compounds exhibited significant anti-HIV-1 activity, especially N-phenylsulfonyl-3-acetyl-6-methylindole (2j) and N-(p-ethyl)phenylsulfonyl-3-acetyl-6-methylindole (2n) showed the most potent anti-HIV-1 activity with EC50 values of 0.36 and 0.13 mu g/mL, and TI values of >555.55 and 791.85, respectively. It demonstrated that introduction of the acetyl group at the 3-position of N-arylsulfonyl-6-methylindoles could generally lead to the more potent analogs. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3534 / 3536
页数：3
相关论文
共 50 条
  • [31] Anti-HIV-1 activity of Trim 37
    Tabah, Azah A.
    Tardif, Keith
    Mansky, Louis M.
    JOURNAL OF GENERAL VIROLOGY, 2014, 95 : 960 - 967
  • [32] In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae
    Nosik, Marina N.
    Krylova, Natalya V.
    Usoltseva, Roza V.
    Surits, Valerii V.
    Kireev, Dmitry E.
    Shchelkanov, Mikhail Yu.
    Svitich, Oxana A.
    Ermakova, Svetlana P.
    MARINE DRUGS, 2024, 22 (08)
  • [33] Computational prediction of anti HIV-1 peptides and in vitro evaluation of anti HIV-1 activity of HIV-1 P24-derived peptides
    Poorinmohammad, Naghmeh
    Mohabatkar, Hassan
    Behbahani, Mandana
    Biria, Davood
    JOURNAL OF PEPTIDE SCIENCE, 2015, 21 (01) : 10 - 16
  • [34] COMPLEMENT-MEDIATED ENHANCEMENT OF HIV-1 INFECTION REVERSES THE ANTI-HIV-1 ACTIVITY OF CASTANOSPERMINE
    MONTEFIORI, DC
    ROBINSON, WE
    MODLISZEWSKI, A
    MITCHELL, WM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 616 : 572 - 574
  • [35] Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine
    Clouser, Christine L.
    Chauhan, Jay
    Bess, Matthew A.
    van Oploo, Jessica L.
    Zhou, Ding
    Dimick-Gray, Sarah
    Mansky, Louis M.
    Patterson, Steven E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (21) : 6642 - 6646
  • [36] In Vitro Anti-HIV-1 Activity of the Aqueous Extract of Asterina Pectinifera
    Karadeniz, Fatih
    Karagozlu, Mustafa Zafer
    Kong, Chang-Suk
    Kim, Se-Kwon
    CURRENT HIV RESEARCH, 2011, 9 (02) : 95 - 102
  • [37] PROBLEMS AND PERSPECTIVES IN THE DESIGN OF ANTI-HIV-1 AGENTS
    MOHAN, P
    DRUG DEVELOPMENT RESEARCH, 1993, 29 (01) : 1 - 17
  • [38] RIBOZYMES AS POTENTIAL ANTI-HIV-1 THERAPEUTIC AGENTS
    SARVER, N
    CANTIN, EM
    CHANG, PS
    ZAIA, JA
    LADNE, PA
    STEPHENS, DA
    ROSSI, JJ
    SCIENCE, 1990, 247 (4947) : 1222 - 1225
  • [39] In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii
    Dinesh, Subramaniam
    Menon, Thangam
    Hanna, Luke E.
    Suresh, V.
    Sathuvan, M.
    Manikannan, M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 82 : 83 - 88
  • [40] Anti HIV-1 Agents 2. Discovery of Dibenzofurans as New HIV-1 Inhibitors In Vitro
    Fan, Ling-Ling
    Liu, Wu-Qing
    Xu, Hui
    Yang, Liu-Meng
    Lv, Min
    Zheng, Yong-Tang
    LETTERS IN DRUG DESIGN & DISCOVERY, 2009, 6 (03) : 178 - 180
12345